Global and United States Artificial Organ and Tissues Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Artificial Organ and Tissues Market
This report focuses on global and United States Artificial Organ and Tissues market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Artificial Organ and Tissues market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Artificial Kidney accounting for % of the Artificial Organ and Tissues global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Medical Use was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Artificial Organ and Tissues market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Artificial Organ and Tissues Scope and Market Size
Artificial Organ and Tissues market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Artificial Organ and Tissues market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Artificial Organ and Tissues market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Artificial Kidney
    Artificial Heart & Ventricular Assist Device
    Cochlear Implant
    Artificial Lung
    Artificial Liver
    Artificial Pancreas
    Bionic Hands & Prosthetics
    Others

Segment by Application
    Medical Use
    Clinical Research

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Spain
        Nordics
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Southeast Asia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Fresenius Medical Care
    Cochlear
    Abiomed
    ABBOTT
    Baxter
    B.Braun
    Asahi Kasei Corporation
    Nipro
    MED-EL
    Toray Medical
    Sonova
    Medtronic
    Getinge (Maquet)
    William Demant
    LivaNova (Sorin)
    Terumo
    Hangzhou Nurotron
    Syncardia
    CorWave
    Listent Medical
    Evaheart
    Open Bionics
    OYMotion Technologies
    Mobius Bionics

 1 Study Coverage
    1.1 Artificial Organ and Tissues Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Artificial Organ and Tissues Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Artificial Organ and Tissues Market Size for the Year 2017-2028
        1.2.2 Global Artificial Organ and Tissues Market Size for the Year 2017-2028
    1.3 Artificial Organ and Tissues Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Artificial Organ and Tissues in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Artificial Organ and Tissues Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Artificial Organ and Tissues Market Dynamics
        1.4.1 Artificial Organ and Tissues Industry Trends
        1.4.2 Artificial Organ and Tissues Market Drivers
        1.4.3 Artificial Organ and Tissues Market Challenges
        1.4.4 Artificial Organ and Tissues Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Artificial Organ and Tissues by Type
    2.1 Artificial Organ and Tissues Market Segment by Type
        2.1.1 Artificial Kidney
        2.1.2 Artificial Heart & Ventricular Assist Device
        2.1.3 Cochlear Implant
        2.1.4 Artificial Lung
        2.1.5 Artificial Liver
        2.1.6 Artificial Pancreas
        2.1.7 Bionic Hands & Prosthetics
        2.1.8 Others
    2.2 Global Artificial Organ and Tissues Market Size by Type (2017, 2022 & 2028)
    2.3 Global Artificial Organ and Tissues Market Size by Type (2017-2028)
    2.4 United States Artificial Organ and Tissues Market Size by Type (2017, 2022 & 2028)
    2.5 United States Artificial Organ and Tissues Market Size by Type (2017-2028)

 3 Artificial Organ and Tissues by Application
    3.1 Artificial Organ and Tissues Market Segment by Application
        3.1.1 Medical Use
        3.1.2 Clinical Research
    3.2 Global Artificial Organ and Tissues Market Size by Application (2017, 2022 & 2028)
    3.3 Global Artificial Organ and Tissues Market Size by Application (2017-2028)
    3.4 United States Artificial Organ and Tissues Market Size by Application (2017, 2022 & 2028)
    3.5 United States Artificial Organ and Tissues Market Size by Application (2017-2028)

 4 Global Artificial Organ and Tissues Competitor Landscape by Company
    4.1 Global Artificial Organ and Tissues Market Size by Company
        4.1.1 Top Global Artificial Organ and Tissues Companies Ranked by Revenue (2021)
        4.1.2 Global Artificial Organ and Tissues Revenue by Player (2017-2022)
    4.2 Global Artificial Organ and Tissues Concentration Ratio (CR)
        4.2.1 Artificial Organ and Tissues Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Artificial Organ and Tissues in 2021
        4.2.3 Global Artificial Organ and Tissues Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Artificial Organ and Tissues Headquarters, Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Artificial Organ and Tissues Headquarters and Area Served
        4.3.2 Global Artificial Organ and Tissues Companies Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Artificial Organ and Tissues Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Artificial Organ and Tissues Market Size by Company
        4.5.1 Top Artificial Organ and Tissues Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Artificial Organ and Tissues Revenue by Players (2020, 2021 & 2022)

 5 Global Artificial Organ and Tissues Market Size by Region
    5.1 Global Artificial Organ and Tissues Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Artificial Organ and Tissues Market Size by Region (2017-2028)
        5.2.1 Global Artificial Organ and Tissues Market Size by Region: 2017-2022
        5.2.2 Global Artificial Organ and Tissues Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Artificial Organ and Tissues Market Size YoY Growth 2017-2028
        6.1.2 North America Artificial Organ and Tissues Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Artificial Organ and Tissues Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Artificial Organ and Tissues Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Southeast Asia
    6.3 Europe
        6.3.1 Europe Artificial Organ and Tissues Market Size YoY Growth 2017-2028
        6.3.2 Europe Artificial Organ and Tissues Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
        6.3.8 Spain
        6.3.9 Nordics
    6.4 Latin America
        6.4.1 Latin America Artificial Organ and Tissues Market Size YoY Growth 2017-2028
        6.4.2 Latin America Artificial Organ and Tissues Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Artificial Organ and Tissues Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Artificial Organ and Tissues Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Fresenius Medical Care
        7.1.1 Fresenius Medical Care Company Details
        7.1.2 Fresenius Medical Care Business Overview
        7.1.3 Fresenius Medical Care Artificial Organ and Tissues Introduction
        7.1.4 Fresenius Medical Care Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.1.5 Fresenius Medical Care Recent Development
    7.2 Cochlear
        7.2.1 Cochlear Company Details
        7.2.2 Cochlear Business Overview
        7.2.3 Cochlear Artificial Organ and Tissues Introduction
        7.2.4 Cochlear Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.2.5 Cochlear Recent Development
    7.3 Abiomed
        7.3.1 Abiomed Company Details
        7.3.2 Abiomed Business Overview
        7.3.3 Abiomed Artificial Organ and Tissues Introduction
        7.3.4 Abiomed Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.3.5 Abiomed Recent Development
    7.4 ABBOTT
        7.4.1 ABBOTT Company Details
        7.4.2 ABBOTT Business Overview
        7.4.3 ABBOTT Artificial Organ and Tissues Introduction
        7.4.4 ABBOTT Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.4.5 ABBOTT Recent Development
    7.5 Baxter
        7.5.1 Baxter Company Details
        7.5.2 Baxter Business Overview
        7.5.3 Baxter Artificial Organ and Tissues Introduction
        7.5.4 Baxter Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.5.5 Baxter Recent Development
    7.6 B.Braun
        7.6.1 B.Braun Company Details
        7.6.2 B.Braun Business Overview
        7.6.3 B.Braun Artificial Organ and Tissues Introduction
        7.6.4 B.Braun Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.6.5 B.Braun Recent Development
    7.7 Asahi Kasei Corporation
        7.7.1 Asahi Kasei Corporation Company Details
        7.7.2 Asahi Kasei Corporation Business Overview
        7.7.3 Asahi Kasei Corporation Artificial Organ and Tissues Introduction
        7.7.4 Asahi Kasei Corporation Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.7.5 Asahi Kasei Corporation Recent Development
    7.8 Nipro
        7.8.1 Nipro Company Details
        7.8.2 Nipro Business Overview
        7.8.3 Nipro Artificial Organ and Tissues Introduction
        7.8.4 Nipro Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.8.5 Nipro Recent Development
    7.9 MED-EL
        7.9.1 MED-EL Company Details
        7.9.2 MED-EL Business Overview
        7.9.3 MED-EL Artificial Organ and Tissues Introduction
        7.9.4 MED-EL Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.9.5 MED-EL Recent Development
    7.10 Toray Medical
        7.10.1 Toray Medical Company Details
        7.10.2 Toray Medical Business Overview
        7.10.3 Toray Medical Artificial Organ and Tissues Introduction
        7.10.4 Toray Medical Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.10.5 Toray Medical Recent Development
    7.11 Sonova
        7.11.1 Sonova Company Details
        7.11.2 Sonova Business Overview
        7.11.3 Sonova Artificial Organ and Tissues Introduction
        7.11.4 Sonova Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.11.5 Sonova Recent Development
    7.12 Medtronic
        7.12.1 Medtronic Company Details
        7.12.2 Medtronic Business Overview
        7.12.3 Medtronic Artificial Organ and Tissues Introduction
        7.12.4 Medtronic Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.12.5 Medtronic Recent Development
    7.13 Getinge (Maquet)
        7.13.1 Getinge (Maquet) Company Details
        7.13.2 Getinge (Maquet) Business Overview
        7.13.3 Getinge (Maquet) Artificial Organ and Tissues Introduction
        7.13.4 Getinge (Maquet) Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.13.5 Getinge (Maquet) Recent Development
    7.14 William Demant
        7.14.1 William Demant Company Details
        7.14.2 William Demant Business Overview
        7.14.3 William Demant Artificial Organ and Tissues Introduction
        7.14.4 William Demant Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.14.5 William Demant Recent Development
    7.15 LivaNova (Sorin)
        7.15.1 LivaNova (Sorin) Company Details
        7.15.2 LivaNova (Sorin) Business Overview
        7.15.3 LivaNova (Sorin) Artificial Organ and Tissues Introduction
        7.15.4 LivaNova (Sorin) Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.15.5 LivaNova (Sorin) Recent Development
    7.16 Terumo
        7.16.1 Terumo Company Details
        7.16.2 Terumo Business Overview
        7.16.3 Terumo Artificial Organ and Tissues Introduction
        7.16.4 Terumo Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.16.5 Terumo Recent Development
    7.17 Hangzhou Nurotron
        7.17.1 Hangzhou Nurotron Company Details
        7.17.2 Hangzhou Nurotron Business Overview
        7.17.3 Hangzhou Nurotron Artificial Organ and Tissues Introduction
        7.17.4 Hangzhou Nurotron Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.17.5 Hangzhou Nurotron Recent Development
    7.18 Syncardia
        7.18.1 Syncardia Company Details
        7.18.2 Syncardia Business Overview
        7.18.3 Syncardia Artificial Organ and Tissues Introduction
        7.18.4 Syncardia Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.18.5 Syncardia Recent Development
    7.19 CorWave
        7.19.1 CorWave Company Details
        7.19.2 CorWave Business Overview
        7.19.3 CorWave Artificial Organ and Tissues Introduction
        7.19.4 CorWave Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.19.5 CorWave Recent Development
    7.20 Listent Medical
        7.20.1 Listent Medical Company Details
        7.20.2 Listent Medical Business Overview
        7.20.3 Listent Medical Artificial Organ and Tissues Introduction
        7.20.4 Listent Medical Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.20.5 Listent Medical Recent Development
    7.21 Evaheart
        7.21.1 Evaheart Company Details
        7.21.2 Evaheart Business Overview
        7.21.3 Evaheart Artificial Organ and Tissues Introduction
        7.21.4 Evaheart Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.21.5 Evaheart Recent Development
    7.22 Open Bionics
        7.22.1 Open Bionics Company Details
        7.22.2 Open Bionics Business Overview
        7.22.3 Open Bionics Artificial Organ and Tissues Introduction
        7.22.4 Open Bionics Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.22.5 Open Bionics Recent Development
    7.23 OYMotion Technologies
        7.23.1 OYMotion Technologies Company Details
        7.23.2 OYMotion Technologies Business Overview
        7.23.3 OYMotion Technologies Artificial Organ and Tissues Introduction
        7.23.4 OYMotion Technologies Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.23.5 OYMotion Technologies Recent Development
    7.24 Mobius Bionics
        7.24.1 Mobius Bionics Company Details
        7.24.2 Mobius Bionics Business Overview
        7.24.3 Mobius Bionics Artificial Organ and Tissues Introduction
        7.24.4 Mobius Bionics Revenue in Artificial Organ and Tissues Business (2017-2022)
        7.24.5 Mobius Bionics Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Artificial Organ and Tissues Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Artificial Organ and Tissues Market Trends
    Table 3. Artificial Organ and Tissues Market Drivers
    Table 4. Artificial Organ and Tissues Market Challenges
    Table 5. Artificial Organ and Tissues Market Restraints
    Table 6. Global Artificial Organ and Tissues Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Artificial Organ and Tissues Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Artificial Organ and Tissues Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Artificial Organ and Tissues Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Artificial Organ and Tissues Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Artificial Organ and Tissues Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Artificial Organ and Tissues Revenue Share by Player, 2017-2022
    Table 13. Global Artificial Organ and Tissues Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Artificial Organ and Tissues by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Organ and Tissues as of 2021)
    Table 15. Top Players of Artificial Organ and Tissues in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Artificial Organ and Tissues Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Artificial Organ and Tissues Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Artificial Organ and Tissues Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Artificial Organ and Tissues Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Artificial Organ and Tissues Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Artificial Organ and Tissues Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Artificial Organ and Tissues Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Artificial Organ and Tissues Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Artificial Organ and Tissues Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Artificial Organ and Tissues Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Artificial Organ and Tissues Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Artificial Organ and Tissues Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Fresenius Medical Care Company Details
    Table 31. Fresenius Medical Care Business Overview
    Table 32. Fresenius Medical Care Artificial Organ and Tissues Product
    Table 33. Fresenius Medical Care Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 34. Fresenius Medical Care Recent Development
    Table 35. Cochlear Company Details
    Table 36. Cochlear Business Overview
    Table 37. Cochlear Artificial Organ and Tissues Product
    Table 38. Cochlear Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 39. Cochlear Recent Development
    Table 40. Abiomed Company Details
    Table 41. Abiomed Business Overview
    Table 42. Abiomed Artificial Organ and Tissues Product
    Table 43. Abiomed Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 44. Abiomed Recent Development
    Table 45. ABBOTT Company Details
    Table 46. ABBOTT Business Overview
    Table 47. ABBOTT Artificial Organ and Tissues Product
    Table 48. ABBOTT Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 49. ABBOTT Recent Development
    Table 50. Baxter Company Details
    Table 51. Baxter Business Overview
    Table 52. Baxter Artificial Organ and Tissues Product
    Table 53. Baxter Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 54. Baxter Recent Development
    Table 55. B.Braun Company Details
    Table 56. B.Braun Business Overview
    Table 57. B.Braun Artificial Organ and Tissues Product
    Table 58. B.Braun Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 59. B.Braun Recent Development
    Table 60. Asahi Kasei Corporation Company Details
    Table 61. Asahi Kasei Corporation Business Overview
    Table 62. Asahi Kasei Corporation Artificial Organ and Tissues Product
    Table 63. Asahi Kasei Corporation Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 64. Asahi Kasei Corporation Recent Development
    Table 65. Nipro Company Details
    Table 66. Nipro Business Overview
    Table 67. Nipro Artificial Organ and Tissues Product
    Table 68. Nipro Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 69. Nipro Recent Development
    Table 70. MED-EL Company Details
    Table 71. MED-EL Business Overview
    Table 72. MED-EL Artificial Organ and Tissues Product
    Table 73. MED-EL Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 74. MED-EL Recent Development
    Table 75. Toray Medical Company Details
    Table 76. Toray Medical Business Overview
    Table 77. Toray Medical Artificial Organ and Tissues Product
    Table 78. Toray Medical Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 79. Toray Medical Recent Development
    Table 80. Sonova Company Details
    Table 81. Sonova Business Overview
    Table 82. Sonova Artificial Organ and Tissues Product
    Table 83. Sonova Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 84. Sonova Recent Development
    Table 85. Medtronic Company Details
    Table 86. Medtronic Business Overview
    Table 87. Medtronic Artificial Organ and Tissues Product
    Table 88. Medtronic Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 89. Medtronic Recent Development
    Table 90. Getinge (Maquet) Company Details
    Table 91. Getinge (Maquet) Business Overview
    Table 92. Getinge (Maquet) Artificial Organ and Tissues Product
    Table 93. Getinge (Maquet) Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 94. Getinge (Maquet) Recent Development
    Table 95. William Demant Company Details
    Table 96. William Demant Business Overview
    Table 97. William Demant Artificial Organ and Tissues Product
    Table 98. William Demant Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 99. William Demant Recent Development
    Table 100. LivaNova (Sorin) Company Details
    Table 101. LivaNova (Sorin) Business Overview
    Table 102. LivaNova (Sorin) Artificial Organ and Tissues Product
    Table 103. LivaNova (Sorin) Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 104. LivaNova (Sorin) Recent Development
    Table 105. Terumo Company Details
    Table 106. Terumo Business Overview
    Table 107. Terumo Artificial Organ and Tissues Product
    Table 108. Terumo Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 109. Terumo Recent Development
    Table 110. Hangzhou Nurotron Company Details
    Table 111. Hangzhou Nurotron Business Overview
    Table 112. Hangzhou Nurotron Artificial Organ and Tissues Product
    Table 113. Hangzhou Nurotron Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 114. Hangzhou Nurotron Recent Development
    Table 115. Syncardia Company Details
    Table 116. Syncardia Business Overview
    Table 117. Syncardia Artificial Organ and Tissues Product
    Table 118. Syncardia Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 119. Syncardia Recent Development
    Table 120. CorWave Company Details
    Table 121. CorWave Business Overview
    Table 122. CorWave Artificial Organ and Tissues Product
    Table 123. CorWave Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 124. CorWave Recent Development
    Table 125. Listent Medical Company Details
    Table 126. Listent Medical Business Overview
    Table 127. Listent Medical Artificial Organ and Tissues Product
    Table 128. Listent Medical Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 129. Listent Medical Recent Development
    Table 130. Evaheart Company Details
    Table 131. Evaheart Business Overview
    Table 132. Evaheart Artificial Organ and Tissues Product
    Table 133. Evaheart Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 134. Evaheart Recent Development
    Table 135. Open Bionics Company Details
    Table 136. Open Bionics Business Overview
    Table 137. Open Bionics Artificial Organ and Tissues Product
    Table 138. Open Bionics Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 139. Open Bionics Recent Development
    Table 140. OYMotion Technologies Company Details
    Table 141. OYMotion Technologies Business Overview
    Table 142. OYMotion Technologies Artificial Organ and Tissues Product
    Table 143. OYMotion Technologies Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 144. OYMotion Technologies Recent Development
    Table 145. Mobius Bionics Company Details
    Table 146. Mobius Bionics Business Overview
    Table 147. Mobius Bionics Artificial Organ and Tissues Product
    Table 148. Mobius Bionics Revenue in Artificial Organ and Tissues Business (2017-2022) & (US$ Million)
    Table 149. Mobius Bionics Recent Development
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Artificial Organ and Tissues Product Picture
    Figure 2. Global Artificial Organ and Tissues Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Artificial Organ and Tissues Market Size 2017-2028 (US$ Million)
    Figure 4. United States Artificial Organ and Tissues Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Artificial Organ and Tissues Market Size 2017-2028 (US$ Million)
    Figure 6. United States Artificial Organ and Tissues Market Share in Global 2017-2028
    Figure 7. Artificial Organ and Tissues Report Years Considered
    Figure 8. Product Picture of Artificial Kidney
    Figure 9. Product Picture of Artificial Heart & Ventricular Assist Device
    Figure 10. Product Picture of Cochlear Implant
    Figure 11. Product Picture of Artificial Lung
    Figure 12. Product Picture of Artificial Liver
    Figure 13. Product Picture of Artificial Pancreas
    Figure 14. Product Picture of Bionic Hands & Prosthetics
    Figure 15. Product Picture of Others
    Figure 16. Global Artificial Organ and Tissues Market Share by Type in 2022 & 2028
    Figure 17. Global Artificial Organ and Tissues Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. Global Artificial Organ and Tissues Market Share by Type (2017-2028)
    Figure 19. United States Artificial Organ and Tissues Market Share by Type in 2022 & 2028
    Figure 20. United States Artificial Organ and Tissues Market Size by Type (2017-2028) & (US$ Million)
    Figure 21. United States Artificial Organ and Tissues Market Share by Type (2017-2028)
    Figure 22. Product Picture of Medical Use
    Figure 23. Product Picture of Clinical Research
    Figure 24. Global Artificial Organ and Tissues Market Share by Application in 2022 & 2028
    Figure 25. Global Artificial Organ and Tissues Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Artificial Organ and Tissues Market Share by Application (2017-2028)
    Figure 27. United States Artificial Organ and Tissues Market Share by Application in 2022 & 2028
    Figure 28. United States Artificial Organ and Tissues Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Artificial Organ and Tissues Market Share by Application (2017-2028)
    Figure 30. North America Artificial Organ and Tissues Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. United States Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Artificial Organ and Tissues Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Spain Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Nordics Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Asia-Pacific Artificial Organ and Tissues Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 42. China Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Japan Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. South Korea Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. India Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Australia Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Southeast Asia Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Artificial Organ and Tissues Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Colombia Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Artificial Organ and Tissues Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. UAE Artificial Organ and Tissues Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Fresenius Medical Care Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 58. Cochlear Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 59. Abiomed Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 60. ABBOTT Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 61. Baxter Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 62. B.Braun Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 63. Asahi Kasei Corporation Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 64. Nipro Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 65. MED-EL Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 66. Toray Medical Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 67. Sonova Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 68. Medtronic Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 69. Getinge (Maquet) Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 70. William Demant Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 71. LivaNova (Sorin) Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 72. Terumo Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 73. Hangzhou Nurotron Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 74. Syncardia Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 75. CorWave Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 76. Listent Medical Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 77. Evaheart Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 78. Open Bionics Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 79. OYMotion Technologies Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 80. Mobius Bionics Revenue Growth Rate in Artificial Organ and Tissues Business (2017-2022)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed

Market Analysis and Insights: Global and United States Artificial Organ and Tissues Market
This report focuses on global and United States Artificial Organ and Tissues market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Artificial Organ and Tissues market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Artificial Kidney accounting for % of the Artificial Organ and Tissues global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Medical Use was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Artificial Organ and Tissues market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Artificial Organ and Tissues Scope and Market Size
Artificial Organ and Tissues market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Artificial Organ and Tissues market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Artificial Organ and Tissues market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Artificial Kidney
    Artificial Heart & Ventricular Assist Device
    Cochlear Implant
    Artificial Lung
    Artificial Liver
    Artificial Pancreas
    Bionic Hands & Prosthetics
    Others

Segment by Application
    Medical Use
    Clinical Research

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Spain
        Nordics
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Southeast Asia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Fresenius Medical Care
    Cochlear
    Abiomed
    ABBOTT
    Baxter
    B.Braun
    Asahi Kasei Corporation
    Nipro
    MED-EL
    Toray Medical
    Sonova
    Medtronic
    Getinge (Maquet)
    William Demant
    LivaNova (Sorin)
    Terumo
    Hangzhou Nurotron
    Syncardia
    CorWave
    Listent Medical
    Evaheart
    Open Bionics
    OYMotion Technologies
    Mobius Bionics